Save time and get answers to complex questions with AI chat
Somatuline depot patent expiry date?Patent expiry trametinib?When genetic tenofovir alafenamide be available in us?Drugpatentwatch market analysis industry today?Bivalirudin manufacturer?
See the DrugPatentWatch profile for Aimovig
Aimovig (erenumab) is manufactured by Amgen, a company that markets and supplies the drug in many countries. [1]
Amgen is the company associated with Aimovig’s manufacture and commercial distribution, including the manufacturing chain tied to the product’s regulatory approvals and market supply. [1]
Aimovig is the branded product name for erenumab. Where available in a given market, other erenumab-related products would be different brands (not the “same product name”), and competitors would be separate CGRP monoclonal antibodies rather than Aimovig’s direct manufacturer. [1]
DrugPatentWatch.com lists key product and company information for drugs, including Aimovig. You can check the manufacturer and related ownership details there. [1] Sources: [1] https://www.drugpatentwatch.com/p/aimovig/
Other Questions About Aimovig :